ArticleFrontiers in bioengineering and biotechnology2026
Bioengineered exosome-mRNA hybrids: a breakthrough in targeted miRNA delivery for diabetic kidney fibrosis therapy.
Jing Ke et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.